In vivo redox metabolic imaging of mitochondria assesses disease progression in non-alcoholic steatohepatitis

[1]  Stephan Weise,et al.  Present and Future , 2019, A Fossil History of Southern African Land Mammals.

[2]  M. Hashizume,et al.  Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging , 2016, Scientific Reports.

[3]  G. Musso,et al.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.

[4]  K. Yasukawa,et al.  Redox imaging of skeletal muscle using in vivo DNP-MRI and its application to an animal model of local inflammation. , 2015, Free radical biology & medicine.

[5]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.

[6]  J. Franconi,et al.  In vivo Overhauser-enhanced MRI of proteolytic activity. , 2014, Contrast media & molecular imaging.

[7]  K. Yasukawa,et al.  Simultaneous and spectroscopic redox molecular imaging of multiple free radical intermediates using dynamic nuclear polarization-magnetic resonance imaging. , 2014, Analytical chemistry.

[8]  D. Mladenović,et al.  Dynamics of oxidative/nitrosative stress in mice with methionine–choline-deficient diet-induced nonalcoholic fatty liver disease , 2014, Human & experimental toxicology.

[9]  F. Nassir,et al.  Role of Mitochondria in Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.

[10]  Sergey Petryakov,et al.  In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe. , 2014, Analytical chemistry.

[11]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[12]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[13]  Giorgio Saracco,et al.  The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.

[14]  Dimitre Hristov,et al.  Multiparametric imaging of tumor oxygenation, redox status, and anatomical structure using overhauser‐enhanced MRI–prepolarized MRI system , 2011, Magnetic resonance in medicine.

[15]  K. Saeian,et al.  Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. , 2011, Annals of diagnostic pathology.

[16]  C. Wilcox.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress. , 2010, Pharmacology & therapeutics.

[17]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[18]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[19]  L. N. Valenti,et al.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.

[20]  G. Tell,et al.  Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. , 2008, Trends in molecular medicine.

[21]  A. Feldstein,et al.  Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future , 2007, Hepatology.

[22]  G. Bedogni,et al.  Predictors of non-alcoholic fatty liver disease in obese children , 2007, European Journal of Clinical Nutrition.

[23]  James B. Mitchell,et al.  The chemistry and biology of nitroxide compounds. , 2007, Free radical biology & medicine.

[24]  Shingo Matsumoto,et al.  Advantageous application of a surface coil to EPR irradiation in overhauser‐enhanced MRI , 2007, Magnetic resonance in medicine.

[25]  James B. Mitchell,et al.  Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. , 2006, Cancer research.

[26]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[27]  James B. Mitchell,et al.  High-Resolution Mapping of Tumor Redox Status by Magnetic Resonance Imaging Using Nitroxides as Redox-Sensitive Contrast Agents , 2006, Clinical Cancer Research.

[28]  D. Pessayre,et al.  Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. , 2006, Mitochondrion.

[29]  Shingo Matsumoto,et al.  Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[31]  H. Blaszyk,et al.  Histologic Variation of Grade and Stage of Non-alcoholic Fatty Liver Disease in Liver Biopsies , 2005, Obesity surgery.

[32]  Gareth R Davies,et al.  Field-cycled PEDRI imaging of free radicals with detection at 450 mT. , 2005, Magnetic resonance imaging.

[33]  A. J. Lambert,et al.  Inhibitors of the Quinone-binding Site Allow Rapid Superoxide Production from Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I)* , 2004, Journal of Biological Chemistry.

[34]  G. Page,et al.  Modification of the Mitochondrial Proteome in Response to the Stress of Ethanol-dependent Hepatotoxicity* , 2004, Journal of Biological Chemistry.

[35]  James B. Mitchell,et al.  Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia. , 2003, Journal of neurosurgery.

[36]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[37]  James B. Mitchell,et al.  Overhauser enhanced magnetic resonance imaging for tumor oximetry: Coregistration of tumor anatomy and tissue oxygen concentration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Dietz,et al.  Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. , 2000, The Journal of pediatrics.

[39]  J. Parks,et al.  Mitochondrial abnormalities in non-alcoholic steatohepatitis. , 1999, Journal of hepatology.

[40]  J. Goldblum,et al.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[41]  H. Kasai,et al.  Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. , 1997, Mutation research.

[42]  G. Placidi,et al.  Young investigator award presentation at the 13th annual meeting of the esmrmb, september 1996, prague , 1996, Magnetic Resonance Materials in Physics, Biology and Medicine.

[43]  V. Skulachev.  Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants , 1996, Quarterly Reviews of Biophysics.

[44]  G. Paradies,et al.  The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. , 1992, Biochimica et biophysica acta.

[45]  A. Grollman,et al.  Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG , 1991, Nature.

[46]  David J. Lurie,et al.  Proton-electron double magnetic resonance imaging of free radical solutions , 1988 .

[47]  E. Gelerinter,et al.  Reduction of the spin-label TEMPONE by ubiquinol in the electron transport chain of intact rabbit spermatozoa. , 1985, Biology of reproduction.

[48]  L. Packer,et al.  Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Overhauser.  Polarization of Nuclei in Metals , 1953 .

[50]  J. George,et al.  Animal models of nonalcoholic fatty liver disease , 2011, Nature Reviews Gastroenterology &Hepatology.

[51]  M. Rigoulet,et al.  Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. , 2008, American journal of physiology. Endocrinology and metabolism.

[52]  F. Yao.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes , 2008 .

[53]  Sang-hun Park.  Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[54]  James B. Mitchell,et al.  Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. , 2002, Cancer research.

[55]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[56]  H. Swartz.  Principles of the metabolism of nitroxides and their implications for spin trapping. , 1990, Free radical research communications.

[57]  P. Canney,et al.  Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? , 1990, The British journal of radiology.

[58]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[59]  R. Brasch,et al.  Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. , 1985, Magnetic resonance imaging.